跳转至内容
Merck

V-015

Supelco

(−)-核黄素 (维生素 B2) 标准液 CRM 溶液

100 μg/mL (Methanol:0.1% Ammonium acetate in Water (1:1)), ampule of 1 mL, analytical standard, Cerilliant®

别名:

(−)-核黄素, 维生素 B2, 乳黄素, 维生素 G

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C17H20N4O6
CAS号:
分子量:
376.36
Beilstein:
97825
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:

等級

analytical standard
certified reference material

形狀

liquid

特點

Snap-N-Spike®/Snap-N-Shoot®

包裝

ampule of 1 mL

製造商/商標名

Cerilliant®

濃度

100 μg/mL (Methanol:0.1% Ammonium acetate in Water (1:1))

mp

290 °C (dec.) (lit.)

應用

clinical testing

格式

single component solution

儲存溫度

2-8°C

SMILES 字串

CC1=C(C)C=C(N(C[C@H](O)[C@@H]([C@H](O)CO)O)C(C2=N3)=NC(NC2=O)=O)C3=C1

InChI

1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1

InChI 密鑰

AUNGANRZJHBGPY-SCRDCRAPSA-N

正在寻找类似产品? 访问 产品对比指南

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

標靶器官

Eyes

儲存類別代碼

3 - Flammable liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

49.5 °F - closed cup

閃點(°C)

9.7 °C - closed cup


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

Slide 1 of 4

1 of 4

Arundhati Biswas et al.
PloS one, 8(3), e58190-e58190 (2013-03-14)
Two potential orthologs of the human riboflavin transporter 3 (hRFVT3) were identified in the C. elegans genome, Y47D7A.16 and Y47D7A.14, which share 33.7 and 30.5% identity, respectively, with hRFVT3. The genes are tandemly arranged, and we assign them the names
Ithar M Beshtawi et al.
Journal of cataract and refractive surgery, 39(3), 451-462 (2013-03-20)
Photodynamic collagen crosslinking (CXL) using ultraviolet-A (UVA) irradiation combined with the photosensitizer riboflavin has been introduced as a new treatment for progressive keratoconus. The results of clinical studies are promising, but the efficacy of the treatment in halting the progression
David T C Lin et al.
Journal of refractive surgery (Thorofare, N.J. : 1995), 28(11 Suppl), S841-S848 (2013-03-02)
To report results of a series of highly aberrated corneas treated with a topography-guided excimer laser ablation. Retrospective, nonrandomized, consecutive series of eyes treated with topography-guided photorefractive keratectomy (TG-PRK) with the customized topographical neutralization technique (TNT). Cases included postoperative refractive
Caroline Butler et al.
The Cochrane database of systematic reviews, 3(3), CD009072-CD009072 (2013-04-02)
Platelet transfusions are used to prevent and treat bleeding in patients who are thrombocytopenic. Despite improvements in donor screening and laboratory testing, a small risk of viral, bacterial or protozoal contamination of platelets remains. There is also an ongoing risk
Madina Mansurova et al.
Chembiochem : a European journal of chemical biology, 14(5), 645-654 (2013-03-05)
Two chemically synthesized flavin derivatives, 8-trifluoromethyl- and 8-bromoriboflavin (8-CF(3)RF and 8-BrRF), were photochemically characterized in H(2)O and studied spectroscopically after incorporation into the LOV domain of the blue light photoreceptor YtvA from Bacillus subtilis. The spectroscopic studies were paralleled by

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门